Experimental Search for New Means of Pathogenetic Therapy COVID-19: Inhibitor of H2-Receptors Famotidine Increases the Effect of Oseltamivir on Survival and Immune Status of Mice Infected by A/PR/8/34 (H1N1)

The development of drugs for the therapy of COVID-19 is one of the main problems of modern physiology, biochemistry and pharmacology. Taking into account the available information on the participation of mast cells and the role of histamine in the pathogenesis of COVID-19, as well as information on...

Descripción completa

Detalles Bibliográficos
Autores principales: Goncharov, N. V., Vasilyev, K. A., Kudryavtsev, I. V., Avdonin, P. P., Belinskaia, D. A., Stukova, M. A., Shamova, O. V., Avdonin, P. V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pleiades Publishing 2022
Materias:
Experimental Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897615/
https://www.ncbi.nlm.nih.gov/pubmed/35283537
http://dx.doi.org/10.1134/S0022093022010203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897615/
https://www.ncbi.nlm.nih.gov/pubmed/35283537
http://dx.doi.org/10.1134/S0022093022010203

Ejemplares similares